AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · IEX Real-Time Price · USD

3.780

-0.060 (-1.56%)

At close: Apr 30, 2024, 4:00 PM

3.810

+0.030 (0.79%)

After-hours: Apr 30, 2024, 7:10 PM EDT

AbCellera Biologics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-146.4	158.52	153.46	118.92	-2.21	0.31
Depreciation & Amortization	30.89	33.1	17.25	5.27	1.85	0.92
Share-Based Compensation	64.18	49.48	30.65	8.4	0.89	0.62
Other Operating Activities	7.44	36.26	43.22	-109.9	2.17	1.72
Operating Cash Flow	-43.88	277.36	244.58	22.69	2.69	3.57
Operating Cash Flow Growth	-	13.40%	977.94%	742.24%	-24.43%	-
Capital Expenditures	-76.95	-70.66	-58.45	-9.67	-4	-5.31
Acquisitions	0	0	-11.46	-87.64	-1.78	0
Change in Investments	-168.91	-296.4	-294.96	-17.46	0	0
Other Investing Activities	24.75	14.43	32.62	-5	-	-
Investing Cash Flow	-221.11	-352.63	-332.25	-119.78	-5.78	-5.31
Share Issuance / Repurchase	0	0	0	522.84	0.03	2.65
Debt Issued / Paid	11.59	2.76	5.49	86.54	0.18	1.98
Other Financing Activities	-1.23	-4.38	-9.37	74.28	-0.01	7.56
Financing Cash Flow	10.36	-1.63	-3.89	683.65	0.2	12.19
Exchange Rate Effect	0.59	-9.6	-1.43	0	0	0
Net Cash Flow	-254.04	-86.49	-92.97	586.56	-2.89	10.44
Free Cash Flow	-120.82	206.7	186.13	13.02	-1.3	-1.74
Free Cash Flow Growth	-	11.05%	1329.91%	-	-	-
Free Cash Flow Margin	-317.75%	42.58%	49.61%	5.58%	-11.22%	-19.73%
Free Cash Flow Per Share	-0.42	0.72	0.68	0.08	-0.01	-0.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).